Global Blood Therapeutics, Inc.

CA · United States · Reporting entity ID 100000771818

Total reported 2019–2025

$25.3M

#277 of 2,960 reporting companies — 0% of all reported industry payments

$6.29M in general payments across 8,719 records, plus $19.0M in research funding across 2,852 records.

How it breaks down

General payments $6,292,520

Research funding $18,958,429

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.